The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells

Holland, M.L., Panetta, J.A., Hoskins, J.M., Bebawy, M., Roufogalis, B.D., Allen, J.D., Arnold, J.C.·2006·Biochemical Pharmacology
DOI 10.1016/j.bcp.2005.12.033

Cited by (156)

Items 101–156 of 156

  1. Cannabinoids in Oncology and Immune Response
    Louis‐Philippe de Lorimier, Trina Hazzah, Erik de Almeida Amazonas, Stephen Niño Cital · 2021 · Springer eBooks
  2. In vitro evaluation of the interaction of the cannabis constituents cannabichromene and cannabichromenic acid with ABCG2 and ABCB1 transporters
    Maia G. Etchart, Lyndsey L. Anderson, Adam Ametovski, Peter M. Jones, Anthony M. George, Samuel D. Banister, Jonathon Carl Arnold · 2022 · European Journal of Pharmacology
  3. Turmeric (Curcuma longa) : An Evidence-Based Systematic Review by the Natural Standard Research Collaboration
    Catherine E. Ulbricht, Ethan Basch, Ernie‐Paul Barrette, Heather Shirley Boon, Wendy Chao, Dawn Costa, Elizabeth R.B. Higdon, Richard Isaac, Margaret Lynch, George N. Papaliodis et al. · 2011 · Alternative and Complementary Therapies
  4. Potential perioperative cardiovascular outcomes in cannabis/cannabinoid users. A call for caution
    Marco Echeverria-Villalobos, Yosira Guevara, Justin Mitchell, David Ryskamp, Joshua Conner, Margo Bush, Luis Periel, Alberto A. Uribe, Tristan E. Weaver · 2024 · Frontiers in Cardiovascular Medicine
  5. Cannabinoids: Chemistry and Medicine
    Giovanni Appendino, Orazio Taglialatela‐Scafati · 2013 · Springer eBooks
  6. Effect of combining CBD with standard breast cancer therapeutics
    Luka Dobovišek, Metka Novak, Fran Krstanović, Simona Borštnar, Tamara Lah Turnšek, Nataša Debeljak · 2022 · Advances in Cancer Biology - Metastasis
  7. Pediatric Dosing Considerations for Medical Cannabis
    Jane Alcorn, Stephanie Vuong, Fang Ping Wu, Blair W. Seifert, Andrew William Lyon · 2019 · IntechOpen eBooks
  8. Cannabis sativa: Cervical cancer treatment- Role of phytocannabinoids-A story of concern
    Ravindra B. Malabadi, Sadiya MR, Prathima TC, Kiran P. Kolkar, Simuzar S. Mammadova, RAJU KRISHNA CHALANNAVAR · 2024 · World Journal of Biology Pharmacy and Health Sciences
  9. Impact of Medical Cannabis on the Quality of Life of Cancer Patients: A Critical Review
    Larissa Gonçalves Correa, Adriana Marcassa Tucci · 2025 · Journal of Integrative and Complementary Medicine
  10. Advancing cervical cancer treatment: integrating cannabinoids, combination therapies and nanotechnology
    S. P. Mathibela, Keith Ntokozo Ncube, Maphuti Tebogo Lebelo, Vanessa Steenkamp · 2025 · Journal of Cancer Research and Clinical Oncology
  11. Cytotoxicity of Cannabinoids in Combination with Traditional Lymphoma Chemotherapeutic Drugs Against Non-Hodgkin’s Lymphoma
    Saba Omer, Mahmoud M Mansour, Satyanarayana R. Pondugula, Muralikrishnan Dhanasekaran, Brad M. Matz, Omer Khan, Dawn Merton Boothe · 2025 · Biomedicines
  12. In vitro anticancer activity and oxidative molecular damage by cannabidiol administered alone and in combination with epirubicin
    Margarita Zhelyazkova, Nadya G. Hristova-Avakumova, Lozan T. Todorov, Georgi Momekov · 2021 · Biotechnology & Biotechnological Equipment
  13. Drug interactions with Cannabis sativa: Mechanisms and clinical implication
    Atena Hasanpoor, Maryam Akaberi, Prashant Kesharwani, Zahra Sobhani, Amirhossein Sahebkar · 2023 · Annales de Toxicologie Analytique
  14. Medical marijuana in cancer: harmful or harm reduction?
    Alexandra Thielmann, Paul Joseph Daeninck · 2013 · Clinical Practice
  15. The Effects of Drugs of Abuse on ABC Transporters
    Noor A. Hussein, Dawn E. Muskiewicz, David Terrero, Saloni Malla, Frank Scott Hall, Amit Kumar Tiwari · 2022 · Springer eBooks
  16. Prevalence of cannabidiol (CBD) consumption and cancer patients’ expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation
    Antoine Le Bozec, Marie Guédon, Mathias Brügel, Maëliss Laurent, Claire Carlier, Dominique Hettler, Marine Perrier, Léa Aubert, Florian Slimano, Céline Mongaret et al. · 2023 · Journal of Oncology Pharmacy Practice
  17. Pharmacogenetics in Epilepsy and Refractory Epilepsy
    Liliana A. Czornyj, Jerónimo Auzmendi, Alberto Lazarowski · 2023 · Springer eBooks
  18. Toxicity effects of Cannabidiol (CBD) on immune cells
    Kanyaruck Jindaphun, Nuchjira Takheaw, Witida Laopajon, Supansa Pata, Watchara Kasinrerk · 2023 · Journal of Associated Medical Sciences
  19. In vitro Effect of Cannabidiol on Red Blood Cells: Implication in Long-Lasting Pathology Treatment
    Claudia Taborda Gómez, Natalia Borda, Franco Moscovicz, Florencia Fernandez, Alberto Lazarowski, Jerónimo Auzmendi · 2024 · Current Pharmaceutical Design
  20. Cannabinoid-Based Medicine: Pharmacology and Drug Interactions
    Mellar P. Davis · 2022 · Springer eBooks
  21. Age-related considerations in the use of cannabinoids: Focus on drug interactions, physiology, and drug effects
    Hanana AlTfaili, Brett C. Ginsburg · 2023 · Elsevier eBooks
  22. Cannabis and Cancer
    Ivan A. Ross · 2023 · Springer eBooks
  23. Implications and quantifications of marijuana use regarding neonatal outcomes
    Zheng Yu, Martin Fitzgerald, Raorao Li, James Amos, Lu Luo · 2022 · Phytomedicine Plus
  24. Cannabis Addiction and COVID-19 Protocols: Are Safety and Efficacy Issues Questionable?
    Mohamed Raslan, Eslam MS, Sara A. R., Nagwa A. Sabri · 2022 · Saudi Journal of Medical and Pharmaceutical Sciences
  25. Emerging Role of Cannabinoid System Modulators in Treatment of Cancer
    Sheetal Singh, Smita Pattanaik, Ravimohan S. Mavuduru, Shrawan Kumar Singh · 2022 · Springer eBooks
  26. Pharmacological actions and associated therapeutic levels of phytocannabinoids Addendum 2021
    Jonathon Carl Arnold, David Allsop, Nicholas Lintzeris, Iain S. McGregor · 2016
  27. Phytocannabinoids as Chemotherapy Adjuncts – a User Guide
    Gerhard Nahler · 2024 · Preprints.org
  28. Genetic association analysis of polymorphisms in four cytochrome P450 genes, the MDR1 gene and treatment-outcome in Xhosa schizophrenia patients
    Erika Truter · 2007 · SUNScholar (Stellenbosch University)
  29. Development and application of a LC-MS/MS method for the analysis of plasma bioavailabilities of different cannabinoids after the administration of "Cannabis sativa L." extracts and MarinolTM
    Sandra Béatrice Grauwiler · 2008 · edoc (University of Basel)
  30. Validation of novel therapeutic target molecules in pediatric sarcomas
    Susanne Oesch · 2009 · Zurich Open Repository and Archive (University of Zurich)
  31. Cannabinoids: Chemistry and Medicine 112
    Giovanni Appendino, Orazio Taglialatela‐Scafati · 2013
  32. The potential of Cannabis Sativa L. aerial plant parts extracts to reverse drug resistance in selected resistant lung- and colon cancer cell lines
    Innocensia Mokgohlwe Mangoato · 2018
  33. CANNABINOID BASED CHEMO-NANOTHERAPY FOR THE TREATMENT OF GYNECOLOGICAL MALIGNANCIES
    Ana Isabel Fraguas‐Sánchez, Ana Isabel Torres‐Suárez, Ana Fernández Carballido · 2020 · Anales de la Real Academia Nacional de Farmacia
  34. The Effects of Drugs of Abuse on ABC Transporters
    Noor A. Hussein, Dawn E. Muskiewicz, David Terrero, Saloni Malla, Frank Scott Hall, Amit Kumar Tiwari · 2022 · Springer eBooks
  35. Peer Review #2 of "ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice (v0.2)"
    2016 · PeerJ
  36. Peer Review #1 of "ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice (v0.1)"
    2016 · PeerJ
  37. Peer Review #1 of "ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice (v0.2)"
    2016 · PeerJ
  38. Peer Review #1 of "Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines (v0.1)"
    2013 · PeerJ
  39. Peer Review #2 of "Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines (v0.1)"
    2013 · PeerJ
  40. Peer Review #3 of "Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines (v0.1)"
    2013 · PeerJ
  41. Peer Review #3 of "ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice (v0.2)"
    2016 · PeerJ
  42. Peer Review #2 of "ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice (v0.1)"
    2016 · PeerJ
  43. Cannabidiol (CBD) Inhibited Rhodamine-123 Efflux in Cultured Vascular Endothelial Cells and Astrocytes under Hypoxic Conditions
    Jerónimo Auzmendi, Pablo H. Palestro, Agustín Blachman, Luciana Gavernet, Amalia Merelli, Alan Talevi, Graciela Cristina Calabrese, Alberto Javier Ramos, Alberto Lazarowski · 2020 · Vide Leaf, Hyderabad eBooks
  44. Peer Review #3 of "ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice (v0.1)"
    2016 · PeerJ
  45. The Role of ABC Transporters in the Actions of Drugs of Abuse
    Saloni Malla, Dawn E. Muskiewicz, Noor A. Hussein, Frank Scott Hall, Amit Kumar Tiwari · 2022 · Springer eBooks
  46. Prevalence of Cannabidiol (CBD) consumption and cancer patients’ expectations in one Oncology Day-Hospital: A cross-sectional study and questionnaire validation
    Antoine Le Bozec, Marie Guédon, Mathias Brügel, Maëliss Laurent, Claire Carlier, Dominique Hettler, Marine Perrier, Léa Aubert, Florian Slimano, Céline Mongaret et al. · 2022 · Research Square
  47. The Role of ABC Transporters in the Actions of Drugs of Abuse
    Saloni Malla, Dawn E. Muskiewicz, Noor A. Hussein, Frank Scott Hall, Amit Kumar Tiwari · 2022 · Springer eBooks
  48. Preparation and Characterization of pH-sensitive Doxorubicin Grafted Hyaluronic Acid Nano-micelles
    Babak Tajani, Arash Mahboubi, Seyyed Mostafa Ebrahimi, Seyed Alireza Mortazavi · 2024 · International Journal of Medical Toxicology and Forensic Medicine
  49. Cannabinoide in der Onkologie und Immunantwort
    Louis‐Philippe de Lorimier, Trina Hazzah, Erik de Almeida Amazonas, Stephen Niño Cital · 2024 · Springer eBooks
  50. The Pharmacokinetic and Pharmacodynamic Drug-drug Interaction Potential of Cannabidiol
    Guillermo Alberto Keller, Jorge Alejandro Aimar · 2025 · Drug Metabolism and Bioanalysis
  51. Chapter 7: Drug Interactions and Pharmacogenetic Considerations
    2025 · The American Pharmacists Association eBooks
  52. Oral Cancer, MiRNAs, and Cannabioids: A Complicated Ménage à Trois
    Andrea De Laurentiis, Manuel Luis Wolfson, Ganna Dmytrenko, Mariana Farina, Fernando Correa · 2026 · Advances in biochemistry in health and disease
  53. Chemical Composition, Classification, and Metabolism of Cannabinoids
    Shahnshah Azam, Luís Loureiro, António Augusto Vicente, Renata Vardanega · 2026 · Springer briefs in molecular science
  54. Membrane exchangers of inorganic cations at the human blood-brain barrier : focus on lithium transport and TRPVs channels in human brain endothelial cells
    Huilong Luo · 2018 · theses.fr (ABES)
  55. Sensibilisation de cellules de mélanome à la chimiothérapie par des flavonoïdes et caroténoïdes extraits de plantes du Brésil, de Nouvelle-Calédonie et de microalgues marines
    Raimundo Gonçalves de Oliveira Júnior · 2020 · theses.fr (ABES)
  56. Cannabinoids in hematologic malignancies: mechanisms and therapeutic potential for overcoming drug resistance
    Sixu Li, Xiaokun Jian, Yufu Tang, Zhentao Wang, Tianjiao Min, Luyao Yu, Beier Jiang, Ying He · 2026 · Frontiers in Pharmacology